Skip to search formSkip to main contentSkip to account menu

fuconojirimycin

Known as: fuco-nojirimycin 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Tumor hypoxia is a major mechanism of resistance to radiation therapy (RT), which is associated with poor prognosis in affected… 
2017
2017
Pigments Class chc2 perid b_fuco fuco h_fuco neo viola pras allo lut zea chl_b Cyanobacteria 0 0 0 0 0 0 0 0 0 0 0.443 0… 
2013
2013
ABSTRACTPurposeTo develop, characterize and exploring the sulfasalazine loaded fucoyslated multi walled carbon nanotubes for… 
2006
2006
An efficient method for examining the selectivity of inhibitors on two alpha-fucosidases, one from Thermotoga maritima and the… 
2004
2004
SummaryIn Escherichia coli the six known genes specifying the utilization of l-fucose as carbon and energy source cluster at 60.2… 
Highly Cited
2003
Highly Cited
2003
Polyhydroxypiperidines and pyrrolidines (also called iminocyclitols or aza-sugars) have attracted increasing attention because of… 
Highly Cited
2002
Highly Cited
2002
We report the fine structure of a nearly contiguous series of N-glycans from the soil nematodeCaenorhabditis elegans. Five major… 
Highly Cited
1990
Highly Cited
1990
Deoxyfuconojirimycin (1,5-dideoxy-1,5-imino-L-fucitol) is a potent, specific and competitive inhibitor (Ki 1 x 10(-8) M) of human…